Showing results (171-180 of 250) with videos related to
Sort By:
Pageof 25
Clinical Breast Cancer|September 6, 2017
Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III TrialsAnna Batistatou, Vassiliki Kotoula, Mattheos Bobos, et al.Breast Cancer Research and Treatment|July 3, 2016
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytesVassiliki Kotoula, Vasilios Karavasilis, Flora Zagouri, et al.Cancer Genomics & Proteomics|April 28, 2017
Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast CancersSofia Levva, Vassiliki Kotoula, Ioannis Kostopoulos, et al.Oncotarget|October 28, 2015
Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trialsVassiliki Kotoula, Kyriakos Chatzopoulos, Sotiris Lakis, et al.Cancer Medicine|September 22, 2018
Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapyMarinos Tsiatas, Konstantine T Kalogeras, Kyriaki Manousou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group TrialPeter Mohr, Axel Hauschild, Uwe Trefzer, et al.The Journal of Investigative Dermatology|March 26, 2016
Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk ScoreKaterina P Kypreou, Irene Stefanaki, Kyriaki Antonopoulou, et al.Plos One|September 30, 2016
Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid ClassesVassiliki Kotoula, Sotiris Lakis, Ioannis S Vlachos, et al.Cancers|January 11, 2024
Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic DepictionDimitrios C Ziogas, Eirini Papadopoulou, Helen Gogas, et al.Anticancer Research|May 7, 2017
Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast CancerTitika-Marina Strati, Vassiliki Kotoula, Ioannis Kostopoulos, et al.Pageof 25